288 related articles for article (PubMed ID: 34862606)
21. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.
Christiano AM; Anhalt G; Gibbons S; Bauer EA; Uitto J
Genomics; 1994 May; 21(1):160-8. PubMed ID: 8088783
[TBL] [Abstract][Full Text] [Related]
22. Oral soft tissues in hereditary epidermolysis bullosa.
Wright JT; Fine JD; Johnson LB
Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):440-6. PubMed ID: 2052329
[TBL] [Abstract][Full Text] [Related]
23. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
24. Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa.
Dourado Alcorte M; Sogayar MC; Demasi MA
Expert Opin Ther Pat; 2019 May; 29(5):327-337. PubMed ID: 31017019
[TBL] [Abstract][Full Text] [Related]
25. Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.
Tartaglia G; Cao Q; Padron ZM; South AP
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065916
[TBL] [Abstract][Full Text] [Related]
26. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
27. Treatment of skin cancers in epidermolysis bullosa.
Venugopal SS; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa.
Feinstein JA; Bruckner AL; Chastek B; Anderson A; Roman J
Orphanet J Rare Dis; 2022 Sep; 17(1):367. PubMed ID: 36175960
[TBL] [Abstract][Full Text] [Related]
30. Disorders of the cutaneous basement membrane zone--the paradigm of epidermolysis bullosa.
Bruckner-Tuderman L; Has C
Matrix Biol; 2014 Jan; 33():29-34. PubMed ID: 23917088
[TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
32. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey.
Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY
J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895
[TBL] [Abstract][Full Text] [Related]
33. Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study.
Bremer J; Pas HH; Diercks GFH; Meijer HJ; van der Molen SM; Nijenhuis AM; van Nijen-Vos LL; Morandé P; Yubero MJ; Palisson F; Fuentes I; Pasmooij AMG
Exp Dermatol; 2024 Feb; 33(2):e15035. PubMed ID: 38389191
[TBL] [Abstract][Full Text] [Related]
34. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.
Krämer S; Lucas J; Gamboa F; Peñarrocha Diago M; Peñarrocha Oltra D; Guzmán-Letelier M; Paul S; Molina G; Sepúlveda L; Araya I; Soto R; Arriagada C; Lucky AW; Mellerio JE; Cornwall R; Alsayer F; Schilke R; Antal MA; Castrillón F; Paredes C; Serrano MC; Clark V
Spec Care Dentist; 2020 Nov; 40 Suppl 1(Suppl 1):3-81. PubMed ID: 33202040
[TBL] [Abstract][Full Text] [Related]
35. Premature termination codons on both alleles of the type VII collagen gene (COL7A1) in three brothers with recessive dystrophic epidermolysis bullosa.
Christiano AM; Suga Y; Greenspan DS; Ogawa H; Uitto J
J Clin Invest; 1995 Mar; 95(3):1328-34. PubMed ID: 7883979
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural findings in epidermolysis bullosa.
Smith LT
Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
[TBL] [Abstract][Full Text] [Related]
37. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
[TBL] [Abstract][Full Text] [Related]
38. Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Duong T; Wong D; Barrett A; Price H
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637494
[TBL] [Abstract][Full Text] [Related]
39. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
[TBL] [Abstract][Full Text] [Related]
40. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]